Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fermland Bio is a Danish biotechnology company specializing in the development and large-scale production of bioactive ingredients through advanced precision fermentation technology. The company primarily focuses on human milk oligosaccharides (HMOs) and other complex carbohydrates intended for use in infant formula, medical nutrition, and dietary supplements. By leveraging proprietary metabolic engineering and fermentation processes, Fermland Bio aims to provide sustainable and cost-effective alternatives to traditional ingredient sourcing. Their expertise spans the entire value chain from strain development and process optimization to industrial-scale manufacturing. The company's products are specifically designed to support gut health, immune function, and cognitive development in infants and adults.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fermland Bio.